Ono Pharmaceutical (OPHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2018 | 12-2017 | 06-2017 | 12-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 581,707 | 351,402 | 825,810 | 935,368 | 981,286 |
| Marketable Securities | 169,657 | 207,376 | 146,695 | 175,726 | 200,851 |
| Receivables | 750,104 | 822,445 | 664,597 | 758,680 | 769,882 |
| Inventories | 294,069 | 269,451 | 238,684 | 211,738 | 238,666 |
| Other current assets | 106,463 | 93,761 | 89,193 | 38,005 | 46,288 |
| TOTAL | $1,901,999 | $1,744,435 | $1,964,979 | $2,119,517 | $2,236,973 |
| Non-Current Assets | |||||
| PPE Net | 929,255 | 824,393 | 760,441 | 708,198 | 797,165 |
| Investments And Advances | 2,271,103 | 2,170,414 | 1,889,389 | 1,785,262 | 1,796,008 |
| Intangibles | 512,514 | 487,894 | 437,549 | 372,512 | 377,310 |
| Other Non-Current Assets | 76,801 | 49,038 | 102,374 | 43,865 | 90,627 |
| TOTAL | $3,789,673 | $3,531,739 | $3,189,753 | $2,909,837 | $3,061,110 |
| Total Assets | $5,691,663 | $5,276,174 | $5,154,731 | $5,029,353 | $5,298,084 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,962 | 3,090 | 3,891 | 3,474 | 3,355 |
| Accounts payable and accrued liabilities | 308,918 | 271,070 | 247,645 | 268,809 | 239,692 |
| Other current liabilities | 252,246 | 220,079 | 224,978 | 177,714 | 205,763 |
| TOTAL | $606,869 | $518,514 | $509,959 | $538,432 | $494,244 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,192 | 3,208 | 4,180 | 5,440 | 5,353 |
| Other Non-Current Liabilities | 42,016 | 76,017 | 76,842 | 87,028 | 105,391 |
| TOTAL | $54,712 | $87,303 | $89,255 | $100,041 | $119,614 |
| Total Liabilities | $661,572 | $605,818 | $599,214 | $638,472 | $613,858 |
| Shareholders' Equity | |||||
| Common Shares | 159,694 | 153,613 | 154,985 | 149,640 | 170,179 |
| Retained earnings | 4,316,769 | 4,002,600 | 4,407,110 | 4,121,739 | 4,479,566 |
| Other shareholders' equity | 746,563 | 700,212 | 571,249 | 631,502 | 448,724 |
| TOTAL | $5,030,091 | $4,670,356 | $4,555,517 | $4,390,881 | $4,684,225 |
| Total Liabilities And Equity | $5,691,663 | $5,276,174 | $5,154,731 | $5,029,353 | $5,298,083 |